Recent Press Releases

Clinical Trial at The Cancer Institute of New Jersey Studies Combination of Vaccine and Hormone Therapy in Treatment of Prostate Cancer

Clinical Trial at The Cancer Institute of New Jersey Studies Combination of Vaccine and Hormone Therapy in Treatment of Prostate Cancer Date: June 1, 2012 New Brunswick, N.J. – Investigators at...

Map could point way to fungus vaccine

Map could point way to fungus vaccine June 1, 2012 (Edmonton) University of Alberta researchers have made breakthrough use of 3-D magnetic resonance technology to map the structure of a common...

AFFiRiS AG: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna

AFFiRiS AG: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna VIENNA, June 5, 2012 /PRNewswire/ -- The worldwide first clinical trial for the development of a Parkinson's vaccine...

Polynoma Commences Phase III Melanoma Vaccine Clinical Trial

Polynoma Commences Phase III Melanoma Vaccine Clinical Trial - First Patient Dosed in Global Study - June 04, 2012 SAN DIEGO--(BUSINESS WIRE)--Polynoma LLC, a U.S. oncology-focused biopharmaceutical...

MiniVax's Pneumocystis Vaccine Candidate Induces Significant anti-Pneumocystis Antibody Responses and Reduced Fungal Load

MiniVax's Pneumocystis Vaccine Candidate Induces Significant anti-Pneumocystis Antibody Responses and Reduced Fungal Load Poster Presented at the 2012 American Thoracic Society (ATS) Conference...

City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem Cells

City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem Cells DUARTE, Calif., May 25, 2012 (BUSINESS WIRE) -- City of Hope was granted a $5,217,004 early...

Advaxis Completes Enrollment in Phase 2 Cervical Cancer Study

Advaxis Completes Enrollment in Phase 2 Cervical Cancer Study PRINCETON, N.J., May 29, 2012 (BUSINESS WIRE) -- Advaxis, Inc. a leader in developing the next generation of immunotherapies for cancer...

A new strategy for developing meningitis vaccines

A new strategy for developing meningitis vaccines 24-May-2012 Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain. Children, elderly...

Positive data with experimental nasal pneumococcal vaccine

Positive data with experimental nasal pneumococcal vaccine 2012-05-25 Eurocine Vaccines' experimental pneumococcal vaccine protected mice against intranasal challenge. The monovalent nasal vaccine...

UCSF Researchers Identify A Potential New HIV Vaccine/Therapy Target

UCSF Researchers Identify A Potential New HIV Vaccine/Therapy Target May 30, 2012 After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of...

Government of Rwanda Introduces Merck's ROTATEQ(R) (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus

Government of Rwanda Introduces Merck's ROTATEQ(R) (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus WHITEHOUSE STATION, N.J., May 25, 2012 (BUSINESS WIRE)...

First Human Study of HIV Vaccine Vacc-C5 to begin

First Human Study of HIV Vaccine Vacc-C5 to begin Oslo 29.05.2012 - Animal Studies Indicate Similar Generation of Immune Responses as Those in HIV Patients who Naturally Suppress the Infection News...

OHSU Oregon National Primate Research Center develops new, safer method for making vaccines

OHSU Oregon National Primate Research Center develops new, safer method for making vaccines 05/29/12 Beaverton, Ore. While vaccines are perhaps medicine's most important success story, there is...

Oral M vaccae results presented at Uganda MDR-TB symposium

Oral M vaccae results presented at Uganda MDR-TB symposium Immunitor presented oral TB vaccine trial at Keystone Symposium in Uganda Immune Network Ltd. (IMMFF:PK), announces that Immunitor presented...

Immune Response BioPharma Terminates Blockbuster MS Drug NeuroVax Partnership Discussions with GSK

Immune Response BioPharma Terminates Blockbuster MS Drug NeuroVax Partnership Discussions with GSK "Immune Response BioPharma, Inc. has the first MS Vaccine a first in class and best in class...

Device may inject a variety of drugs without using needles

Device may inject a variety of drugs without using needles Jet-injected drugs could improve patient compliance, reduce accidental needle sticks Getting a shot at the doctor's office may become less...

U.S. Government Supports Phase 3 Study of Bavarian Nordic's Smallpox Vaccine

U.S. Government Supports Phase 3 Study of Bavarian Nordic's Smallpox Vaccine Contract Modification Adds $32 Million to the Total Contract Value KVISTGÅRD, Denmark, May 22, 2012 /PRNewswire...

Bavarian Nordic to Report New PROSTVAC® Clinical Data at the American Society of Clinical Oncology Annual Meeting

Bavarian Nordic to Report New PROSTVAC® Clinical Data at the American Society of Clinical Oncology Annual Meeting KVISTGAARD, Denmark, May 18, 2012 - Bavarian Nordic A/S (OMX:BAVA.CO - News)...

A Possible Target for Broad-Range HPV Therapeutics Emerges

A Possible Target for Broad-Range HPV Therapeutics Emerges A highly conserved protein sequence represents the first potential, broad-range HPV drug target Release Date: May 21, 2012 BUFFALO, N.Y. --...

HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine

HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine Total of 48 Subjects To Be Enrolled at Four Sites Across U.S. ATLANTA, May 22, 2012...